Paper Details
- Home
- Paper Details
Infant Exposure to Armodafinil Through Human Milk Following Maternal Use of Modafinil.
Author: CostiLynn, ElliotDavid, HagueWilliam M, LeggettCatherine, MangoniArduino A, RitchieUsha
Original Abstract of the Article :
Narcolepsy, a condition adversely affecting psychological, social, and cognitive function, is more prevalent in females of childbearing age than the general population. Modafinil and armodafinil are central nervous system stimulants approved for treatment of narcolepsy. Infant exposure to these agen...See full text at original site
Dr.Camel's Paper Summary Blogラクダ博士について
ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。
* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。
引用元:
https://doi.org/10.1177/08903344221134273
データ提供:米国国立医学図書館(NLM)
Modafinil and Armodafinil: A Desert Oasis for Narcolepsy?
Narcolepsy, a neurological disorder that disrupts sleep-wake cycles, can significantly impact an individual's quality of life. This research examines the potential for infant exposure to armodafinil, a wakefulness-promoting medication, through human milk following maternal use of modafinil, a related medication commonly prescribed for narcolepsy. The study highlights the limited safety information available regarding the use of these medications during lactation. The researchers emphasize the need for comprehensive safety data to ensure the well-being of both mother and infant. The authors highlight the potential risks of medication exposure through breast milk and the need for careful consideration and informed decision-making when it comes to breastfeeding while taking modafinil or armodafinil.
Navigating the Desert of Medication Safety: A Guide for Breastfeeding Mothers
This study underscores the importance of careful consideration of medication safety during breastfeeding. Women taking modafinil or armodafinil should consult with their doctor or lactation consultant to discuss the potential risks and benefits of breastfeeding.
A Balancing Act: Protecting Both Mother and Child
The research emphasizes the need for greater transparency and information sharing regarding medication safety during lactation. By providing comprehensive and evidence-based information, healthcare professionals can empower breastfeeding mothers to make informed decisions that prioritize the well-being of both themselves and their infants.
Dr.Camel's Conclusion
This study highlights the need for greater vigilance in ensuring medication safety for both mothers and infants, particularly during breastfeeding. Like navigating a vast desert, where every decision matters, healthcare professionals must carefully consider the potential risks and benefits of medication use during lactation, providing mothers with the necessary information to make informed choices for their health and the well-being of their children.
Date :
- Date Completed 2023-04-20
- Date Revised 2023-04-26
Further Info :
Related Literature
English
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.